The 2nd line of the headline said
...Buy the rumour, sell the news....
It's how smart people make money buy cheap sell high.
-Dave
True, though there was a bit of an issue surrounding WHEN he changed the predetermined parts of his plan. Seems like thesee were updated August 19th of 2020, see here:
On Aug. 19, Bourla implemented his stock-trading plan, according to his disclosure to the Securities and Exchange Commission.
The next day, Aug. 20, Pfizer issued a press release featuring "additional Phase 1 safety and immunogenicity data" and confirming that Pfizer and its German partner, BioNTech, were "on track to seek regulatory review" for its vaccine candidate by October.
"It's wholly inappropriate for executives at pharmaceutical companies to be implementing or modifying 10b5-1 plans the business day before they announce data or results from drug trials," Taylor said.
Nothing to really look at in regards to him setting a price and hope it goes up to that. It'd be a bit of a different conversation if he had changed these predetermined parts of his plan right when he was told about the news. But regulators will most likely look into it and determine if there was any violation here.
